Karyopharm Therapeutics Inc. sell Lokrim
Start price
08.04.20
/
50%
€17.60
Target price
04.11.21
-
Performance (%)
-60.19%
End price
05.11.21
€7.01
Summary
This prediction ended on 05.11.21 with a price of €7.01. The SELL prediction by Lokrim for Karyopharm Therapeutics Inc. performed very well with a performance of -60.19%. Lokrim has a follow-up prediction for Karyopharm Therapeutics Inc. where he still thinks Karyopharm Therapeutics Inc. is a Sell. Lokrim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | -3.617% | -3.617% | -55.825% | -86.247% |
| iShares Core DAX® | 4.094% | 4.888% | 17.421% | 22.413% |
| iShares Nasdaq 100 | 1.424% | -0.445% | 37.618% | 58.203% |
| iShares Nikkei 225® | -1.572% | -4.911% | 12.951% | 7.961% |
| iShares S&P 500 | 1.822% | 0.776% | 29.182% | 49.914% |
According to Lokrim what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Lokrim for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Sell Karyopharm Therapeutics Inc.
In the thread Trading Karyopharm Therapeutics Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Current prediction by Lokrim for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
05.02.24
05.02.24
-
05.02.25
05.02.25
-17.64%
13.05.24
13.05.24
Risky Investment
Stopped prediction by Lokrim for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.24
11.12.21
11.12.21
-
11.12.22
11.12.22
-16.73%
08.12.22
08.12.22
Risky Investment